UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 139

Sortiert nach

Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)

International journal of molecular sciences, 2019-08, Vol.20 (15), p.3821

2019

Volltextzugriff (PDF)

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study

BMC cancer, 2021-07, Vol.21 (1), p.1-859, Article 859

2021

Volltextzugriff (PDF)

Design of Wearable Breathing Sound Monitoring System for Real-Time Wheeze Detection

Sensors (Basel, Switzerland), 2017-01, Vol.17 (1), p.171-171

2017

Volltextzugriff (PDF)

Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer

PloS one, 2024-05, Vol.19 (5), p.e0303046

2024

Volltextzugriff (PDF)

The effect of age and resilience on the dose-response function between the number of adversity factors and subjective well-being

Frontiers in psychology, 2024, Vol.15, p.1332124-1332124

2024

Volltextzugriff (PDF)

Roles of lung-recruited monocytes and pulmonary Vascular Endothelial Growth Factor (VEGF) in resolving Ventilator-Induced Lung Injury (VILI)

PloS one, 2021-03, Vol.16 (3), p.e0248959-e0248959

2021

Volltextzugriff (PDF)

Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model

Oncology reports, 2019-08, Vol.42 (2), p.697-707

2019

Volltextzugriff (PDF)

The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis

Scientific reports, 2022-03, Vol.12 (1), p.4398-4398, Article 4398

2022

Volltextzugriff (PDF)

Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung Adenocarcinoma

Cancers, 2022-01, Vol.14 (3), p.674

2022

Volltextzugriff (PDF)

Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI

Cancers, 2022-02, Vol.14 (4), p.977

2022

Volltextzugriff (PDF)

Predictors of Invasive Adenocarcinomas among Pure Ground-Glass Nodules Less Than 2 cm in Diameter

Cancers, 2021-08, Vol.13 (16), p.3945

2021

Volltextzugriff (PDF)

Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer Patients

Cancers, 2022-10, Vol.14 (20), p.5095

2022

Volltextzugriff (PDF)

Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational Study

Vaccines (Basel), 2021-10, Vol.9 (10), p.1122

2021

Volltextzugriff (PDF)

A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed

BMC cancer, 2021-03, Vol.21 (1), p.309-309, Article 309

2021

Volltextzugriff (PDF)

Forced Overexpression of Signal Transducer and Activator of Transcription 3 (STAT3) Activates Yes-Associated Protein (YAP) Expression and Increases the Invasion and Proliferation Abilities of Small Cell Lung Cancer (SCLC) Cells

Biomedicines, 2022-07, Vol.10 (7), p.1704

2022

Volltextzugriff (PDF)

The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer

Biomedicines, 2018-12, Vol.6 (4), p.114

2018

Volltextzugriff (PDF)

Diffusion Tensor Imaging Revealing the Relation of Age-Related Differences in the Corpus Callosum With Cognitive Style

Frontiers in human neuroscience, 2020-07, Vol.14, p.285-285

2020

Volltextzugriff (PDF)

Stomatin-like protein 2 regulates survivin expression in non-small cell lung cancer cells through β-catenin signaling pathway

Cell death & disease, 2018-03, Vol.9 (4), p.425-11, Article 425

2018

Volltextzugriff (PDF)

DNA methylation signature of psychological resilience in young adults: Constructing a methylation risk score using a machine learning method

Frontiers in genetics, 2023-01, Vol.13, p.1046700-1046700

2023

Volltextzugriff (PDF)

Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation

Frontiers in immunology, 2022-10, Vol.13, p.1011092-1011092

2022

Volltextzugriff (PDF)

Preparedness and Best Practice in Radiology Department for COVID-19 and Other Future Pandemics of Severe Acute Respiratory Infection

Journal of thoracic imaging, 2020-07, Vol.35 (4), p.239

2020

Volltextzugriff (PDF)

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study

Journal of clinical oncology, 2023-02, Vol.41 (6), p.1213-1227

2023

Volltextzugriff (PDF)

Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation

Cancers, 2022-01, Vol.14 (2), p.316

2022

Volltextzugriff (PDF)

Concomitant infection with COVID-19 and Mycoplasma pneumoniae

Biomedical Journal, 2020-10, Vol.43 (5), p.458-461

2020

Volltextzugriff (PDF)

Chinese holistic processing: Evidence from cognitive mental architecture using Systems Factorial Technology

Heliyon, 2023-09, Vol.9 (9), p.e19736-e19736, Article e19736

2023

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(133)

Publikationsform

Artikel
(139)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study

Design of Wearable Breathing Sound Monitoring System for Real-Time Wheeze Detection

Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer

The effect of age and resilience on the dose-response function between the number of adversity factors and subjective well-being

Roles of lung-recruited monocytes and pulmonary Vascular Endothelial Growth Factor (VEGF) in resolving Ventilator-Induced Lung Injury (VILI)

Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model

The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis

Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung Adenocarcinoma

Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI

Predictors of Invasive Adenocarcinomas among Pure Ground-Glass Nodules Less Than 2 cm in Diameter

Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer Patients

Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational Study

A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed

Forced Overexpression of Signal Transducer and Activator of Transcription 3 (STAT3) Activates Yes-Associated Protein (YAP) Expression and Increases the Invasion and Proliferation Abilities of Small Cell Lung Cancer (SCLC) Cells

The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer

Diffusion Tensor Imaging Revealing the Relation of Age-Related Differences in the Corpus Callosum With Cognitive Style

Stomatin-like protein 2 regulates survivin expression in non-small cell lung cancer cells through β-catenin signaling pathway

DNA methylation signature of psychological resilience in young adults: Constructing a methylation risk score using a machine learning method

Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation

Preparedness and Best Practice in Radiology Department for COVID-19 and Other Future Pandemics of Severe Acute Respiratory Infection

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study

Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation

Concomitant infection with COVID-19 and Mycoplasma pneumoniae

Chinese holistic processing: Evidence from cognitive mental architecture using Systems Factorial Technology

Aktive Filter

Suchergebnisse filtern